Part 2: Regulatory Challenges With Data Collection
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…
CertaraOctober 31, 2024
Part 1: Complexities in Data Collection
In this video interview with ACT editor Andy Studna, Erin Erginer, director of product, Certara…
CertaraOctober 31, 2024
Mathematical Modeling and the Monkey King: Use of Modeling for More Efficient NHP Study Design
Background Monkeys and humans share a strong bond, reflected not only in a shared genetic…
CertaraOctober 30, 2024
Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women
The article titled "Using PBPK modeling to supplement clinical data and support the safe and…
CertaraOctober 30, 2024
The Complete Guide to CDISC Standards Management
Learn how to easily manage and validate against CDISC data standards our complete guide to…
CertaraOctober 30, 2024
Certara Announces New Head of Clinical Pharmacology & Translational Medical Group
RADNOR, PA – October 30, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraOctober 30, 2024
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment
Abstract: T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy.…
CertaraOctober 29, 2024
Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions
Early Feasibility Assessment (EFA) can impact early drug discovery decisions such as determining feasibility of…
CertaraOctober 29, 2024
Certara to Participate in the Stephens Annual Investment Conference
RADNOR, Pa. — October 28, 2024 -- Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraOctober 28, 2024
Pharma Exec: MDMA Therapy for Mental Health Conditions
Certara's Dr. Fran Brown, SVP Drug Development Science, is featured in this recent Pharmaceutical Executive…
CertaraOctober 28, 2024
